In light of the aforementioned literature, we speculated that MTA1 could potentially influence the development of experimental colitis with regulation of the HIF1A/AQP4 axis and subsequently performed a series of experiments to validate the same, in an effort to uncover novel diagnostic and therapeutic modalities against experimental colitis. This evidence concerns the gene HIF1A and colitis.